Literature DB >> 15367635

Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface.

Beatriz Maroto1, Noelia Valle, Rainer Saffrich, José M Almendral.   

Abstract

It is uncertain whether nonenveloped karyophilic virus particles may actively traffic from the nucleus outward. The unordered amino-terminal domain of the VP2 major structural protein (2Nt) of the icosahedral parvovirus minute virus of mice (MVM) is internal in empty capsids, but it is exposed outside of the shell through the fivefold axis of symmetry in virions with an encapsidated single-stranded DNA genome, as well as in empty capsids subjected to a heat-induced structural transition. In productive infections of transformed and normal fibroblasts, mature MVM virions were found to efficiently exit from the nucleus prior to cell lysis, in contrast to the extended nuclear accumulation of empty capsids. Newly formed mutant viruses lacking the three phosphorylated serine residues of 2Nt were hampered in their exit from the human transformed NB324K nucleus, in correspondence with the capacity of 2Nt to drive microinjected phosphorylated heated capsids out of the nucleus. However, in normal mouse A9 fibroblasts, in which the MVM capsid was phosphorylated at similar sites but with a much lower rate, the nuclear exit of virions and microinjected capsids harboring exposed 2Nt required the infection process and was highly sensitive to inhibition of the exportin CRM1 in the absence of a demonstrable interaction. Thus, the MVM virion exits the nucleus by accessing nonconventional export pathways relying on cell physiology that can be intensified by infection but in which the exposure of 2Nt remains essential for transport. The flexible 2Nt nuclear transport signal may illustrate a common structural solution used by nonenveloped spherical viruses to propagate in undamaged host tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367635      PMCID: PMC516424          DOI: 10.1128/JVI.78.19.10685-10694.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Exportin 1 (Crm1p) is an essential nuclear export factor.

Authors:  K Stade; C S Ford; C Guthrie; K Weis
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

2.  Evidence for a role of CRM1 in signal-mediated nuclear protein export.

Authors:  B Ossareh-Nazari; F Bachelerie; C Dargemont
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

3.  The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs.

Authors:  U Fischer; J Huber; W C Boelens; I W Mattaj; R Lührmann
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

4.  Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor.

Authors:  U Kutay; F R Bischoff; S Kostka; R Kraft; D Görlich
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

5.  CRM1 is an export receptor for leucine-rich nuclear export signals.

Authors:  M Fornerod; M Ohno; M Yoshida; I W Mattaj
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

6.  Requirement of guanosine triphosphate-bound ran for signal-mediated nuclear protein export.

Authors:  S A Richards; K L Carey; I G Macara
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

7.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

Authors:  B Wolff; J J Sanglier; Y Wang
Journal:  Chem Biol       Date:  1997-02

8.  Parvovirus minute virus of mice strain i multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons.

Authors:  J C Ramírez; A Fairén; J M Almendral
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  The NS2 polypeptide of parvovirus MVM is required for capsid assembly in murine cells.

Authors:  S F Cotmore; A M D'Abramo; L F Carbonell; J Bratton; P Tattersall
Journal:  Virology       Date:  1997-05-12       Impact factor: 3.616

10.  Protein species of the parvovirus minute virus of mice strain MVMp: involvement of phosphorylated VP-2 subtypes in viral morphogenesis.

Authors:  J F Santarén; J C Ramírez; J M Almendral
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more
  35 in total

1.  Reorganization of Nuclear Pore Complexes and the Lamina in Late-Stage Parvovirus Infection.

Authors:  Elina Mäntylä; Einari A Niskanen; Teemu O Ihalainen; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.

Authors:  Ning Zhi; Ian P Mills; Jun Lu; Susan Wong; Claudia Filippone; Kevin E Brown
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.

Authors:  Bernhard Mani; Claudia Baltzer; Noelia Valle; José M Almendral; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Manipulation of the mechanical properties of a virus by protein engineering.

Authors:  Carolina Carrasco; Milagros Castellanos; Pedro J de Pablo; Mauricio G Mateu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

5.  An in-frame deletion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions.

Authors:  Nadine Weiss; Alexandra Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Nathalie Salomé
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

6.  The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwise-transformed human fibroblasts.

Authors:  Justin Paglino; Peter Tattersall
Journal:  Virology       Date:  2011-05-20       Impact factor: 3.616

7.  Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.

Authors:  Mari-Paz Rubio; Alberto López-Bueno; José M Almendral
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  A supraphysiological nuclear export signal is required for parvovirus nuclear export.

Authors:  Dieuwke Engelsma; Noelia Valle; Alexander Fish; Nathalie Salomé; José M Almendral; Maarten Fornerod
Journal:  Mol Biol Cell       Date:  2008-04-02       Impact factor: 4.138

9.  Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Authors:  Assia L Angelova; Svitlana P Grekova; Anette Heller; Olga Kuhlmann; Esther Soyka; Thomas Giese; Marc Aprahamian; Gaétan Bour; Sven Rüffer; Celina Cziepluch; Laurent Daeffler; Jean Rommelaere; Jens Werner; Zahari Raykov; Nathalia A Giese
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

10.  Viral oncolysis that targets Raf-1 signaling control of nuclear transport.

Authors:  Laura Riolobos; Noelia Valle; Eva Hernando; Beatriz Maroto; Michael Kann; José M Almendral
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.